Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

ClinicalTrials.gov ID: NCT02367781

Public ClinicalTrials.gov record NCT02367781. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 9:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Atezolizumab (MPDL3280A, Anti-PD-L1 Antibody) in Combination With Carboplatin+Nab-Paclitaxel for Chemotherapy-Naive Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer

Study identification

NCT ID
NCT02367781
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
723 participants

Conditions and interventions

Interventions

  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody Drug
  • Carboplatin Drug
  • Nab-Paclitaxel Drug
  • Pemetrexed Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 15, 2015
Primary completion
Mar 14, 2018
Completion
Jan 17, 2021
Last update posted
Aug 8, 2021

2015 – 2021

United States locations

U.S. sites
57
U.S. states
25
U.S. cities
55
Facility City State ZIP Site status
Highlands Oncology Group Springdale Arkansas 72762
Kaiser Permanente Oakland Medical Center Oakland California 94611
Kaiser Permanente Medical Center - Roseville Roseville California 95661
Kaiser Permanente - Sacramento Medical Center and Medical Offices Sacramento California 95825
Kaiser Permanente - San Francisco Medical Center San Francisco California 94118
Kaiser Permanente - San Jose Medical Center San Jose California 95119
Kaiser Permanente - San Leandro Medical Center San Leandro California 94577
Kaiser Permanente - Santa Clara Santa Clara California 95051
Kaiser Permanente - South San Francisco South San Francisco California 94080
Kaiser Permanente; Oncology Clinical Trials Vallejo California 94589
Kaiser Permanente - Walnut Creek Walnut Creek California 94596
Banner MD Anderson Cancer Center Greeley Colorado 85234
Eastern Connecticut Hematology and Oncology Associates; (ECHO) Norwich Connecticut 06360
University of Miami School of Medicine - Sylvester at Deerfield Deerfield Beach Florida Suite 200
SCRI Florida Cancer Specialists South Fort Myers Florida 33916
Florida Hospital Orlando Florida 32803
Florida Cancer Specialists (St. Petersburg - St. Anthony's Professional Building) St. Petersburg Florida 33705
SCRI Florida Cancer Specialists East West Palm Beach Florida 33401
University Cancer & Blood Center, LLC; Research Athens Georgia 30607
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital Carrollton Georgia 30117
Suburban Hematology / Oncology Associates Lawrenceville Georgia 30046
Southeastern Regional Medical Center, Inc. Newnan Georgia 30265
University of Illinois at Chicago Chicago Illinois 60612
Joliet Oncology-Hematology; Associates, Ltd. Joliet Illinois 60435
Illinois Cancer Care Peoria Illinois 61615
Quincy Medical Group Quincy Illinois 62301
Southern Illinois University, Simmons Cancer Institute Springfield Illinois 62794
Fort Wayne Med Oncology & Hematology Inc Fort Wayne Indiana 46845
University of Iowa Hospitals and Clinics Iowa City Iowa 52242-1083
Lahey Clinic Med Ctr Lexington Kentucky 02421
Walter Reed National Military Medical Center Bethesda Maryland 20814
Center For Cancer and Blood Disorders Bethesda Maryland 20817
Southcoast Health System Fairhaven Massachusetts 02719
Mayo Clinic Rochester Minnesota 55905
Hematology and Oncology Associates at Bridgepoint Tupelo Mississippi 38801
Southeast Nebraska Cancer Ctr Lincoln Nebraska 68510
Va Sierra Nevada Health Care System Reno Nevada 89502
Englewood Hospital and Medical Center Englewood New Jersey 07631
Saint Barnabas Medical Center Livingston New Jersey 07039
Cancer Inst. of New Jersey New Brunswick New Jersey 08901
Laura and ISAAC Perlmutter Cancer Center at NYU Langone. New York New York 10016
Clinical Research Alliance Westbury New York 11590
Presbyterian Hospital Charlotte North Carolina 28204
Duke University Medical Center; Department of Medicine Durham North Carolina 27710
W.G. Bill Hefner VA Medical Center Salisbury North Carolina
The Christ Hospital Cincinnati Ohio 45219
Mark H. Zangmeister Center Columbus Ohio 43219
Oncology Hematology Care, Inc. Hamilton Ohio 45103
Pinnacle Health Harrisburg Pennsylvania 17110
Lancaster General Hospital Lancaster Pennsylvania 17604
Rhode Island Hospital Providence Rhode Island 02903
Greenville Health System; Cancer Center Greenville South Carolina 29605-4292
University Oncology Associates Chattanooga Tennessee 37403
SCRI Tennessee Oncology Chattanooga Chattanooga Tennessee 37404
SCRI The Center For Cancer and Blood Disorders Denton Texas 76210
University of Texas M.D. Anderson Cancer Center Houston Texas 77030
Cancer Care Network of South Texas - SAT & BC San Antonio Texas 78217

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02367781, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 8, 2021 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02367781 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →